Compugen Ltd. (TLV:CGEN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 781.60
-12.40 (-1.56%)
Feb 20, 2025, 5:24 PM IDT
Compugen Market Cap
Compugen has a market cap or net worth of 670.22 million as of February 21, 2025. Its market cap has decreased by -7.60% in one year.
Market Cap
670.22M
Enterprise Value
278.99M
Revenue
222.49M
Ranking
n/a
PE Ratio
112.76
Stock Price
781.60
Market Cap Chart
Since August 11, 2000, Compugen's market cap has increased from 289.89M to 670.22M, an increase of 131.20%. That is a compound annual growth rate of 3.47%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 69.16B |
| Danel (Adir Yeoshua) | 2.53B |
| Kamada | 1.57B |
| Bait Bakfar | 1.09B |
| Novolog (Pharm-Up 1966) | 907.03M |
| Ilex Medical | 800.59M |
| BrainsWay | 762.81M |
| SofWave Medical | 597.96M |